Delivering future health solutions.
Health & Life Sciences
#1 Biomanufacturing cluster in Europe
1st Life Sciences University Technical College in UK
#1 Research institution in the world for Tropical Medicine
One of largest concentrations of Cat 3 laboratories in the UK
There is no better validation of Liverpool City Region’s medical credentials than the global players that choose to locate and reinvest here. From stem cell and gene therapy treatments and nutraceuticals research and development, to large scale manufacturing and the production of pharmaceuticals, vaccines and biologics.
Liverpool City region is home to companies delivering world-class solutions in life sciences from research and trials to medical manufacturing, including AstraZeneca; Allergan; Baxter Healthcare, Bristol Myers Squibb; Lilly; Nestlé Health Science; Seqirus and Unilever. Significant new investments in modern production facilities at these companies have created a vibrant, efficient and cost-competitive environment to produce new drugs and vaccines.
The emergence of sensor technologies, big data and robotics is changing the possibilities and processes in the life sciences sector. Liverpool City Region is leading the way with its LCR 4.0 programme, creating a new infrastructure that connects physical and digital assets to make the industrial internet a reality. The Hartree Centre at Sci-Tech Daresbury is shaping the future of digital UK pharmaceutical design, development and manufacturing through big data analytics expertise.
Latest Health & Life Sciences news
New cancer hospital to open in Liverpool City Region’s Knowledge Quarter in June
A multi-million pound centre offering world class cancer treatment will open in Liverpool’s Knowledge Quarter in June.
Liverpool City Region manufacturer targets £2m global export push
Specialist Liverpool City Region manufacturer Heap & Partners is poised to launch a trio of new product lines and is targeting £2m worth of exports in the first three years.
Liverpool chemical tech firm secures a further £2.25m
Liverpool City Region chemical technology firm ChiroChem has secured a funding boost of £2.25m.
CASE STUDY: AstraZeneca
Liverpool City Region works to help AstraZeneca push the boundaries of science to deliver life-changing medicines across the world.
New Royal Liverpool Hospital opens for Covid-19 patients
Part of Liverpool City Region’s new 646-bed Royal Hospital scheme will open to provide care for patients recovering from the virus.
LIVERPOOL CITY REFRIGERATION FIRM BOOSTS PRODUCTION TO TACKLE COVID-19
Liverpool City Region’s refrigeration appliance supplier, Lec Medical is reporting a surge in demand in the UK and across the world due to the coronavirus pandemic.
Liverpool City Region medical firm switches production to join COVID-19 battle
A specialist Merseyside healthcare business has joined the fight against the coronavirus epidemic by switching production to produce vital medical equipment.